Processa pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference

Hanover, md, march 07, 2023 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), the developer of the next generation chemotherapy drugs that will provide a better safety-efficacy profile than their widely used fda-approved counterparts, today announced that the company's president & ceo, dr. david young, will present virtually at the oppenheimer 33rd annual healthcare conference on march 14, 2023 at 12:00 pm eastern. the company is looking forward to sharing its progress on key programs and upcoming data milestones.
PCSA Ratings Summary
PCSA Quant Ranking